Aptose Biosciences
APTO1.7100.00% ( 0.000 )
Q4 FY2024 Earnings
Financial report interval: 2024.10.01 - 2024.12.31
Overview: Aptose Biosciences(APTO) the EBIT is -2.187 M (+81.97%);the EPS is -1.34 (+97.08%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B81.97%
----
----
EPS
-1.337397.08%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf